Quadrivalent and high-dose vaccines offer diverse demographic needs, while digital platforms aid vaccine monitoring and distribution. A robust government backing, ongoing research and development, and ...

A groundbreaking new malaria vaccine that could be three times more effective than existing jabs is under development by ...

The U.S. Food and Drug Administration (FDA) is planning to require all new vaccines to undergo placebo-controlled trials ...

The Trump administration is investing $500M in a project to develop "universal" vaccines that protect against multiple virus ...

Explore the latest NSCLC new treatments in development, including candidates aimed at tackling hard-to-treat, late-stage lung ...

The FDA approved AstraZeneca's Truqap in November 2023 for the treatment of advanced HR-positive breast cancer.

It’s an incredibly exciting time for AstraZeneca in Canada,” says Gaby Bourbara, President, AstraZeneca Canada. “Since 2023, we have invested $4.3 billion in Canada’s l ...

Gennova has been working on self-amplifying mRNA vaccine. mRNA vaccines use body’s machinery to make antigenic protein rather ...

Some telehealth companies that offered compounded GLP-1s have disappeared altogether. Others are pursuing strategies that ...

Analysis found 25% tariff on pharmaceutical imports would hike U.S. drug costs by nearly $51 billion annually, boosting ...

Jenny Strasburg is a reporter in London, where she writes for The Wall Street Journal about oil and gas, climate, the ...

Bojan Pancevski is The Wall Street Journal’s chief European political correspondent, covering European and global affairs. He ...